287 related articles for article (PubMed ID: 33002091)
1. PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis.
Dhaouadi T; Abdellatif J; Trabelsi R; Gaied H; Chamkhi S; Sfar I; Goucha R; Ben Hamida F; Ben Abdallah T; Gorgi Y
PLoS One; 2020; 15(10):e0240025. PubMed ID: 33002091
[TBL] [Abstract][Full Text] [Related]
2. PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians.
Ramachandran R; Kumar V; Kumar A; Yadav AK; Nada R; Kumar H; Kumar V; Rathi M; Kohli HS; Gupta KL; Sakhuja V; Jha V
Nephrol Dial Transplant; 2016 Sep; 31(9):1486-93. PubMed ID: 26673907
[TBL] [Abstract][Full Text] [Related]
3. Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy.
Liu X; Xu W; Yu C; Wang M; Liu R; Xie R
Bioengineered; 2021 Dec; 12(1):8833-8844. PubMed ID: 34607530
[TBL] [Abstract][Full Text] [Related]
4. Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy.
Stefan G; Stancu S; Zugravu A; Popa O; Zubidat D; Petre N; Mircescu G
Ren Fail; 2022 Dec; 44(1):258-268. PubMed ID: 35172682
[TBL] [Abstract][Full Text] [Related]
5. Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy.
Li X; Wei D; Zhou Z; Wang B; Xu Y; Pan J; Yang C; Lu J; Qiu Y
Med Sci Monit; 2016 May; 22():1630-6. PubMed ID: 27179439
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.
Pourcine F; Dahan K; Mihout F; Cachanado M; Brocheriou I; Debiec H; Ronco P
PLoS One; 2017; 12(3):e0173201. PubMed ID: 28257452
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipase A2 Receptor Antibody Levels Predict the Risk of Posttransplantation Recurrence of Membranous Nephropathy.
Quintana LF; Blasco M; Seras M; Pérez NS; López-Hoyos M; Villarroel P; Rodrigo E; Viñas O; Ercilla G; Diekmann F; Gómez-Roman JJ; Fernandez-Fresnedo G; Oppenheimer F; Arias M; Campistol JM
Transplantation; 2015 Aug; 99(8):1709-14. PubMed ID: 25675198
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
Zhou K; Zhou J; Zhou L; Xue J; Liu B; Zhang Z; Zhang X; Cai T; Shao S; Huang B; Zhang Y; Hu Z; Wang L; Liu X
PLoS One; 2024; 19(5):e0302100. PubMed ID: 38718066
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.
Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA
Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885
[TBL] [Abstract][Full Text] [Related]
10. Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.
Barrett C; Willcocks LC; Jones RB; Tarzi RM; Henderson RB; Cai G; Gisbert SI; Belson AS; Savage CO
Nephrol Dial Transplant; 2020 Apr; 35(4):599-606. PubMed ID: 31243451
[TBL] [Abstract][Full Text] [Related]
11. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE
Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522
[TBL] [Abstract][Full Text] [Related]
12. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy.
Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z
Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to M-type phospholipase A2 receptor (PLA
Garcia-Vives E; Solé C; Moliné T; Alvarez-Rios AM; Vidal M; Agraz I; Ordi-Ros J; Cortés-Hernández J
Lupus; 2019 Mar; 28(3):396-405. PubMed ID: 30760090
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of phospholipase A2 receptor in primary membranous nephropathy: a systematic review and meta-analysis.
Li W; Zhao Y
Int Urol Nephrol; 2019 Sep; 51(9):1581-1596. PubMed ID: 31140029
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.
Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA
J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.
Oh YJ; Yang SH; Kim DK; Kang SW; Kim YS
PLoS One; 2013; 8(4):e62151. PubMed ID: 23637987
[TBL] [Abstract][Full Text] [Related]
17. Clinical Predictive Value of Phospholipase A2 Receptor Gene Polymorphism Combined with Subclass of Immunoglobulin G in Renal Tissues for Membranous Nephropathy.
Ji C; Xu Q; Bian X
Altern Ther Health Med; 2023 Oct; 29(7):418-423. PubMed ID: 37535917
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
19. Circulating antibodies to α-enolase and phospholipase A
Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
[TBL] [Abstract][Full Text] [Related]
20. Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy.
Tampoia M; Migliucci F; Villani C; Abbracciavento L; Rossini M; Fumarulo R; Gesualdo L; Montinaro V
J Nephrol; 2018 Dec; 31(6):899-905. PubMed ID: 30187382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
